SERUM ADENOSINE DEAMINASE LEVEL IN TYPE 2 DIABETIC PATIENTS AND ITS ASSOCIATION WITH HEMOGLOBIN A1C
Keywords:
Adenosine deaminase, Ankle brachial index, Glycemic status, type 2 diabetes mellitusAbstract
Background: Type 2 diabetes mellitus is a common metabolic disorder characterized by hyperglycemia. Elevated adenosine deaminase levels have been observed in diabetic individuals, but their relationship with glycemic control remains an area of interest. This study aims to investigate the serum adenosine deaminase levels in accord to the glycemic status and ABI in type 2 diabetic patients. Methods: This was a cross-sectional study was carried at Department of Medicine, DHQ Hospital Kotri from 06 December 2023 to 06 June 2024 after approval from research ethics committee. The study participants were 140 type 2 diabetic patients and they were categorized as uncontrolled (HbA1c > 7%) and controlled (HbA1c <7%). After informed consent, adenosine deaminase levels were measured in serum samples from both groups. The catered data was entered and analyzed in statistical software of IBM, SPSS version 22.0. Results: The adenosine deaminase was compared according to glycemic status of diabetic patients, there was statistically significant increase in adenosine deaminase levels in patients with hemoglobin A 1c >7.0%. Conclusion: There is increase in adenosine deaminase with increase in hemoglobin A1C. A decrease in ABI is seen with increase in adenosine deaminse levels.
References
1. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, et al. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001;21(2):105–28.
2. Flinn AM, Gennery AR. Adenosine deaminase deficiency: a review. Orphanet J Rare Dis 2018;13(1):65.
3. Niraula A, Thapa S, Kunwar S, Lamsal M, Baral N, Maskey R. Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?. BMC Endocr Disord 2018;18(1):58.
4. Yu C, Zhuang L, Xu F, Zhao LH, Wang XH, Wang CH, et al. Increased levels of serum adenosine deaminase and increased risk of diabetic peripheral neuropathy in type 2 diabetes. Front Endocrinol (Lausanne) 2022;13:997672.
5. Lu CF, Ge XQ, Wang Y, Su JB, Wang XQ, Zhang DM, et al. The relationship between adenosine deaminase and heart rate-corrected QT interval in type 2 diabetic patients. Endocr Connect 2021;10(8):894-901.
6. Larijani B, Heshmat R, Ebrahimi-Rad M, Khatami S, Valadbeigi S, Saghiri R. Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus. Enzyme Res 2016;2016:9526593.
7. Hasan SU, Siddiqui MR. Nationwide prevalence of type 2 diabetes mellitus and pre-diabetes in Pakistan: A systematic review and meta-analysis. Diabetes Res Clin Pract 2024;216:111815.
8. Talebi Mehrdar M, Ebadi G. Increased levels of serum adenosine deaminase (ADA) enzyme and increased risk of T cell activation markers in type 2 diabetes. Cell Mol Biomed Rep 2024;4(3):159–67.
9. Kumar R, Chhatwal S, Arora S, Sharma S, Singh J, Singh N, et al. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes 2013;6:49–56.
10. Cao J, Wang H, Su JB, Wang XQ, Zhang DM, Wang XH, et al. Inverse relationship between serum adenosine deaminase levels and islet beta cell function in patients with type 2 diabetes. Diabetol Metab Syndr 2021;13:54.
11. Kutryb-Zajac B, Mateuszuk L, Zukowska P, Jasztal A, Zabielska MA, Toczek M, et al. Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition. Cardiovasc Res 2016;112(2):590–605.
12. Singh P, Khan S, Kumar MR. Adenosine deaminase activity and its relation with glycated hemoglobin and uric acid in type 2 diabetic patients. Iran J Diabetes Obes 2013;5(1):1–6.
13. Khemka VK, Bagchi D, Ghosh A, Sen O, Bir A, Chakrabarti S, et al. Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus. Sci World J 2013;2013:404320.
14. Sapkota LB, Thapa S, Subedi N. Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2017;5(1):e000357.
15. Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab 2020;319(5):E827–34
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ramesh Kumar Suthar, Atif Ahmed, Kuldeep Kumar Poorani, Kashif Ali, Ali Akbar Nangraj, Bedarbakhat

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.



